CPOHPC acid,
R-1-(6-(R-2-carboxy-pyrrolidin-1-yl)-6-oxo-hexanoyl)pyrrolidine-2-carboxylic acid,
R-1-(6-(R-2-carboxypyrrolidin-1-yl)-6-oxohexanoyl)pyrrolidine-2-carboxylic acid,
cphpc,
Miridesap,
224624-80-0,
UNII-WO97N24A47,
Ro 63-8695,
GSK2315698,
WO97N24A47,
R-1-(6-(R-2-carboxypyrrolidin-1-yl)-6-oxohexanoyl)pyrrolidine-2-carboxylic acid,
(2R)-1-[6-[(2R)-2-carboxypyrrolidin-1-yl]-6-oxohexanoyl]pyrrolidine-2-carboxylic acid,
CPOHPC acid,
(2r)-1-[6-[(2r)-2-Carboxypyrrolidin-1-Yl]-6-Oxidanylidene-Hexanoyl]pyrrolidine-2-Carboxylic Acid,
4avt,
GHE,
Miridesap [USAN],
Ro-63-8695,
AC1L2OP8,
1,1'-(1,6-Dioxo-1,6-hexanediyl)bis-D-proline,
CHEMBL25263,
1,1'-hexanedioyldi-D-proline,
GTPL8256,
SCHEMBL1537496,
DTXSID00176996,
HZLAWYIBLZNRFZ-VXGBXAGGSA-N,
ZINC3972138,
AKOS030528069,
compound 52 [PMID 14998318],
DB13087,
HY-101861,
LS-192450,
CS-0022098,
A17078,
D-Proline, 1,1'-(1,6-dioxo-1,6-hexanediyl)bis-,
(R)-1-[6-[(R)-2-carboxy-pyrrolidin-1-yl]-6-oxo-hexanoyl]-pyrrolidine-2-carboxylic acid,
r-1-[6-[r-2-carboxy-pyrrolidin-1-yl]-6-oxo-hexanoyl] pyrrolidine-2-carboxylic acid,
(2R,2'R)-1,1'-(1,6-dioxohexane-1,6-diyl)dipyrrolidine-2-carboxylic acid (non-preferred name),
Amyloid beta inhibitor,
D05FBZ,
SAP binding inhibitor, Roche,
CID125516,
C16-H24-N2-O6,
Serum amyloid P binding inhibitor, Roche,